Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The dark side of cannabis: increased risk of psychosis

Ken Finn, MD
Conditions
January 31, 2023
Share
Tweet
Share

Psychosis is a broad term that describes a change in the perception of reality. It can be caused by various conditions, including metabolic, psychiatric, neurologic, genetic, and other medical conditions, as well as licit and illicit substances, particularly cannabis. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) states that abnormalities define these disorders in one or more of the following five domains: delusions, hallucinations, disorganized thinking (speech), grossly disorganized or abnormal motor behavior (including catatonia), and negative symptoms.

Cannabis-induced psychosis has been subject to debate but is becoming more prevalent in areas where use rates are increasing. This increase may be related to improved diagnostic evaluation, medical coding, increased understanding of the condition, and increased cannabis potency. Studies have shown a 3-fold increased risk of psychosis with “skunk,” which is generally accepted as cannabis with more than 10 percent tetrahydrocannabinol (THC) content.

Violence associated with psychosis has also been well-documented. Marijuana use may be associated with increased impulsivity on the same day and the following day relative to days when marijuana was not used. It is also associated with increased hostile behaviors and perceptions of hostility in others on the same day compared to days when marijuana was not used. Cannabis use disorder appears to increase the risk of aggression towards others, particularly among youths. There is also evidence of a moderate association between cannabis use and physical violence.

Psychosis can be caused by various conditions, including licit and illicit substances, particularly cannabis. Cannabis has a higher conversion rate to psychosis than other substances. 32 percent of patients with substance-induced psychosis convert to either bipolar or schizophrenia-spectrum disorders, with the highest conversion rate found with cannabis-induced psychosis (47 percent). There is debate about the causal relationship between cannabis and psychosis. However, this can be demonstrated using Bradford-Hill criteria. Despite this, psychosis is often multifactorial in many instances. Cannabis exposure increases the risk of psychosis, from transient psychotic states to chronic recurrent psychosis. In individuals with established psychosis, cannabis has a negative impact on the course and expression of the illness.

Individuals who use cannabis frequently are at an increased risk of psychosis, with no significant risk associated with less frequent use. There is a significant dose-response association between cannabis use frequency and psychosis development. Frequently overlooked is the fact that psychosis precipitated by cannabis use may persist, despite cessation, and may not resolve. Recent data shows that hospitalizations for psychosis/cannabis use are more likely in areas where cannabis is legalized, and recreational cannabis legalization is associated with a greater rate of hospitalization for psychosis associated with cannabis use.

Several likely factors contribute to the trend of cannabis-induced psychosis, including increased normalization of cannabis use, decreased perception of harm, rapid development of higher potency products in recent years, and products with less cannabidiol, which has been shown to have a potential protective effect. Furthermore, progression to schizophrenia is highest in those with cannabis-induced psychotic disorder and is predicted by early age at diagnosis of substance-induced psychotic disorder, male sex, and other episodes of drug abuse, alcohol use disorder, and substance-induced psychotic disorder.

Adolescents who use cannabis report more psychotic-like symptoms than controls and more than adults, independent of depression and anxiety. Delaying onset of use, discouraging the use of products with greater than 10 percent THC content and preventing daily or near-daily use should be part of the educational process, starting at early ages. Potency caps should be mandated as “high potency” cannabis should be considered in any product with greater than 10 percent THC due to a 5-fold risk of developing psychosis, according to more recent data.

It would be critical that areas expanding cannabis programs seriously consider mandatory drug testing on any violent crime, including mass shootings, which are becoming more prevalent, and make those findings public. Public health campaigns, underscoring the health risks of cannabis, including psychosis, should be strongly encouraged and disseminated to the medical community, general public, and state legislators to allow for better-informed policy development. Consistency in testing is strongly recommended. The potential relationship between cannabis use and psychosis cannot be ignored.

Ken Finn is a physiatrist.

Prev

Be a prepared physician: laceration repair kits for your home, vacation home, and cars

January 31, 2023 Kevin 0
…
Next

The dark side of celebrity medicine

January 31, 2023 Kevin 0
…

Tagged as: Medications

Post navigation

< Previous Post
Be a prepared physician: laceration repair kits for your home, vacation home, and cars
Next Post >
The dark side of celebrity medicine

ADVERTISEMENT

Related Posts

  • The risk physicians take when going on social media

    Anonymous
  • The can and can’t of cannabis

    Eunice Zhang, MD
  • Cannabis stigma continues to impede patient care

    Jill Becker, MD
  • Clearing the misinformation surrounding medical cannabis

    Samoon Ahmad, MD and Kevin Hill, MD
  • 5 urban legends about risk-adjusted diagnosis coding

    Betsy Nicoletti, MS
  • Federal legalization of cannabis: What does it mean for patients?

    Jill Becker, MD

More in Conditions

  • Medicaid lags behind on Alzheimer’s blood test coverage

    Amanda Matter
  • Why transgender health care needs urgent reform and inclusive practices

    Angela Rodriguez, MD
  • Why the Sean Combs trial is a wake-up call for HIV prevention

    Catherine Diamond, MD
  • New surge in misleading ads about diabetes on social media poses a serious health risk

    Laura Syron
  • mRNA post vaccination syndrome: Is it real?

    Harry Oken, MD
  • The critical role of nurse practitioners in colorectal cancer screening

    Elisabeth Evans, FNP
  • Most Popular

  • Past Week

    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • How federal actions threaten vaccine policy and trust

      American College of Physicians | Conditions
    • Are we repeating the statin playbook with lipoprotein(a)?

      Larry Kaskel, MD | Conditions
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
    • Closing the diversity gap in Parkinson’s research

      Vicky Chan | Conditions
    • Medicaid lags behind on Alzheimer’s blood test coverage

      Amanda Matter | Conditions
  • Past 6 Months

    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • Why so many doctors secretly feel like imposters

      Ryan Nadelson, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • A physician employment agreement term that often tricks physicians

      Dennis Hursh, Esq | Finance
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
  • Recent Posts

    • Medicaid lags behind on Alzheimer’s blood test coverage

      Amanda Matter | Conditions
    • The unspoken contract between doctors and patients explained

      Matthew G. Checketts, DO | Physician
    • AI isn’t hallucinating, it’s fabricating—and that’s a problem [PODCAST]

      The Podcast by KevinMD | Podcast
    • Brooklyn hepatitis C cluster reveals hidden dangers in outpatient clinics

      Don Weiss, MD, MPH | Policy
    • The truth in medicine: Why connection matters most

      Ryan Nadelson, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • How federal actions threaten vaccine policy and trust

      American College of Physicians | Conditions
    • Are we repeating the statin playbook with lipoprotein(a)?

      Larry Kaskel, MD | Conditions
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
    • Closing the diversity gap in Parkinson’s research

      Vicky Chan | Conditions
    • Medicaid lags behind on Alzheimer’s blood test coverage

      Amanda Matter | Conditions
  • Past 6 Months

    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • Why so many doctors secretly feel like imposters

      Ryan Nadelson, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • A physician employment agreement term that often tricks physicians

      Dennis Hursh, Esq | Finance
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
  • Recent Posts

    • Medicaid lags behind on Alzheimer’s blood test coverage

      Amanda Matter | Conditions
    • The unspoken contract between doctors and patients explained

      Matthew G. Checketts, DO | Physician
    • AI isn’t hallucinating, it’s fabricating—and that’s a problem [PODCAST]

      The Podcast by KevinMD | Podcast
    • Brooklyn hepatitis C cluster reveals hidden dangers in outpatient clinics

      Don Weiss, MD, MPH | Policy
    • The truth in medicine: Why connection matters most

      Ryan Nadelson, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

The dark side of cannabis: increased risk of psychosis
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...